Follow The Filings

SPH

Earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by SPH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All SPH insider trades
  • None no insider bought on the open market
  • $59K sold by 2 insiders outside a trading plan
  • $193K sold by 1 insider under 10b5-1 plans
  1. Jane Swift Director
    Sale
    $8,443 512 shares at $16.49 1.4% of stake
    Traded Sep 28–29 Filed Sep 29
    ↗
  2. Bryon L Koepke VP,General Counsel & Secretary
    Sale
    $50K 2,848 shares at $17.65 2.8% of stake
    Traded Aug 31 Filed Sep 1
    ↗
  3. Matthew J Chanin Director
    Planned sale
    $193K 10,000 shares at $19.31 14% of stake
    Traded Dec 2, 2025 Filed Dec 4, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 20 sales back to the company, 19 option exercises, 14 stock grants, and 12 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,2.03,8.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
10-K Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.